Reports of Sexual Disorders Related to Serotonin Reuptake Inhibitors in the French Pharmacovigilance Database: An Example of Underreporting

被引：0
|
作者：
Thierry Trenque
Géric Maura
Emmanuelle Herlem
Catherine Vallet
Elodie Sole
Pascal Auriche
Moustapha Drame
机构：
[1] Reims University Teaching Hospitals,Regional Centre for Pharmacovigilance and Pharmacoepidemiology
[2] University of Reims Champagne-Ardenne,Faculty of Medicine
[3] ANSM,Pharmacovigilance Department
[4] Reims University Hospitals,Department of Research and Innovation
来源：
Drug Safety | 2013年 / 36卷
关键词：
Sexual Dysfunction; Fluvoxamine; Duloxetine; Escitalopram; Premature Ejaculation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：515 / 519
页数：4
相关论文
共 50 条
  • [21] Hypertension associated with serotonin reuptake inhibitors: A new analysis in the WHO pharmacovigilance database and examination of dose-dependency
    Chretien, Basile
    Rabiaza, Andry
    Kazuki, Nishida
    Fedrizzi, Sophie
    Sassier, Marion
    Dolladille, Charles
    Alexandre, Joachim
    Humbert, Xavier
    PLOS ONE, 2025, 20 (03):
  • [22] SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN THE TREATMENT OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS
    BEJEROT, S
    HUMBLE, M
    PSYCHOPHARMACOLOGY, 1995, 118 (02) : B5 - B5
  • [23] Serotonin-selective reuptake inhibitors in the treatment of geriatric depression and related disorders
    Mulchahey, JJ
    Malik, MS
    Sabai, M
    Kasckow, JW
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 1999, 2 (02): : 121 - 127
  • [24] Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders
    Stein, DJ
    Bouwer, C
    Hawkridge, S
    Emsley, RA
    JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (03) : 119 - 122
  • [25] Pharmacovigilance of Selective Serotonin Reuptake Inhibitors and Gender Differences in Stroke Incidence
    Pezzullo, A. M.
    Ferraro, C.
    Sellitto, C.
    Iannaccone, T.
    Giudice, V.
    Centola, R.
    Manzo, V.
    Salvo, F.
    Filippelli, A.
    DRUG SAFETY, 2022, 45 (10) : 1262 - 1263
  • [26] Selective serotonin reuptake inhibitors and manic switch: A pharmacovigilance and pharmacodynamical study
    Ciray, R. Ogulcan
    Halac, Eren
    Turan, Serkan
    Tuncturk, Mustafa
    Ozbek, Mutlu
    Ermis, Cagatay
    ASIAN JOURNAL OF PSYCHIATRY, 2021, 66
  • [27] Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
    Tan, Boyu
    Chen, Li
    Yan, Sulan
    Pan, Huijie
    Zhang, Jingxian
    Wei, Hongyan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] Hypertension induced by serotonin reuptake inhibitors: analysis of two pharmacovigilance databases
    Humbert, Xavier
    Fedrizzi, Sophie
    Chretien, Basile
    Sassier, Marion
    Bagheri, Haleh
    Combret, Sandrine
    Drici, Milou-Daniel
    Le Bas, Francois
    Puddu, Paolo E.
    Alexandre, Joachim
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (03) : 296 - 302
  • [29] Effects of selective serotonin reuptake inhibitors on sexual function
    Altman, CA
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (02) : 241 - 242
  • [30] Sexual dysfunction associated with serotonin specific reuptake inhibitors
    Herran, A
    PalaciosAraus, L
    VazquezBarquero, JL
    DiezManrique, JF
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (01) : 67 - 68
12345